'The Global Market for Large Joint Reconstruction Devices Will be Worth $22.6bn by 2022' Says Visiongain's Report

LONDON, October 18, 2012 /PRNewswire/ --

A new report by Visiongain, a London-based business information provider, predicts that the global market for large joint reconstruction devices will be worth $22.6bn by 2022. This market generated sales of $12.8bn in 2011. Although, the large joint reconstruction market remained under pressure in 2011 owing to decrease in procedure volumes, high unemployment rates and increase in pricing pressures, the market is expected to achieve strong growth during the forecast period 2012-2022. Hip and knee implants constitute the major segments of this sector. Key factors in the growth of this market will be the global aging population and rising incidence of obesity.

Amritha.M.Ramakrishnan, healthcare industry analyst, says: "New product innovations, new surgical techniques and better implant materials will drive growth in the coming years. There is a trend towards the use of minimally invasive procedures, customised implants and robotic technologies, which is expected to grow during the forecast period. Moreover, increased direct-to-consumer marketing has raised awareness of available treatments, fuelling market growth. The emerging countries like India and China are expected to achieve strong growth during the forecasted period driven by their fast growing economies. There is a large sector of consumers who can now afford the costly replacement procedures."
Visiongain's research also identifies that 90% of the global large joint reconstruction market is controlled by five leading companies - Zimmer, DePuy, Stryker, Smith & Nephew and Biomet. Each of these companies has an extensive portfolio of time tested hip and knee implants. Other significant players include Aesculap, Wright Medical Technology and Exactech. With economic and pricing pressures affecting the market leaders, smaller companies are finding a window of opportunity to grab a portion of the market share. In 2011, the US led the large joint reconstruction devices market with total sales of $6.8bn, accounting for 52.8% of the global market.

Visiongain predicts that the large joint reconstruction market will grow steadily to 2022. The future of large joint reconstruction devices market definitely appears promising and exciting. As more patients will require orthopaedic treatments to maintain their active lifestyle, the orthopaedic companies can witness huge potential for growth and investment. This new report adds to visiongain's wide range of analytical reports in healthcare and other industry areas.

For further information concerning the Visiongain's Large Joint Reconstruction: Global Market Prospects 2012-2022 report please visit http://www.visiongain.com/Report/910/Large-Joint-Reconstruction-Global-Market-Prospects-2012-2022

For an executive summary please contact: Sara Peerun sara.peerun@visiongainglobal.com or Tel: +44 (0) 20 7336

Companies Listed

AAP Implantate AG
Anantha Ortho System
AristoTech Implant Technologies GmbH
B.Braun Melsungen AG
Biomet
BioPro International Inc
Beznoska s.r.o.
Biotechni Orthopedie
Ceraver
ConforMIS Inc
Consensus Orthopedics
Corentec Co Ltd
Corin Group PLC
Covision
Depuy
Enztec
Orthodynamics
Finsbury Orthopaedics
FH Orthopaedics
Forginal Industrie
Lima Corporate s.p.a
Implants International
Intech Medical
Japan Medical Dynamic Marketing
JRI Orthopedics
Kinamed
Lafitt
Mathys AG Bettlach
MAKO Surgical Corp
MEDACTA International SA
Medin
Merete Medical Inc
MetriMed
Omni Life Science
Ortho Development Corporation
Orthodynamics Ltd
Orthopedic Innovation Limited
OTIS Biotech
Permedica Manufacturing SpA
Serf Dedienne santé
Smith & Nephew
StelKast
Stryker
Stanmore Implants
Waldemar Link GmbH & Co. KG
Zimmer

About visiongain
Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, visiongain produces a host of business-2-business conferences, newsletters, management reports and e-zines focusing on the Energy, Telecoms, Pharmaceutical, Defence, Materials sectors.

Visiongain publishes reports produced by its in-house analysts, who are qualified experts in their field. Visiongain has firmly established itself as the first port-of-call for the business professional, who needs independent, high quality, original material to rely and depend on.

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongainglobal.com or call her on +44(0)207-336-6100